drugset / Trial / NCT01261065

Mechanisms of Improvement With Beta-Blocker Treatment in Heart Failure

NCT01261065

Phase 4 Completed 55 enrolled Michael E. DeBakey VA Medical Center
NaSingle-groupOpen-labelDiagnostic

Summary

The overall hypothesis of this application is that the improvement in LV ejection performance following treatment with betablockers is due, at least in part, to improvement in intrinsic myocardial contractility.

Timeline

Start
2001-12
Primary completion
2005-10
Completion
2005-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Carvedilol Other / unclassified 25 mg
Subject Carvedilol Other / unclassified 37.5 mg